Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AngioDynamicsSTU:UG2 -3.28%64 OCF Margin % is 20.15% as of May. 2026, which is 4012% above its 10-year median of 0.49. GuruFocus rates STU:UG2 with a GF Score™ of 64/100 and a GF Value™ of €8.32 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 817 Medical Devices & Instruments companies, AngioDynamics ranks worse than 59% on this metric.
The historical rank and industry rank for AngioDynamics's OCF Margin % or its related term are showing as below:
STU:UG2'
s OCF Margin % Range Over the Past 10 Years
Min: -9.27 Med: 0.49 Max: 20.66
Current: 0.97
During the past 13 years, the highest OCF Margin % of AngioDynamics was 20.66%. The lowest was -9.27%. And the median was 0.49%.
STU:UG2's OCF Margin % is ranked worse than 59% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 5.82
vs STU:UG2: 0.97
AngioDynamics OCF Margin % Related Terms
AngioDynamics OCF Margin % Historical Data
* Premium members only.
The historical data trend for AngioDynamics's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
STU:UG2 vs NNNN, OSUR, UTMD: OCF Margin % Comparison
For the Medical Instruments & Supplies subindustry, AngioDynamics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AngioDynamics OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AngioDynamics's OCF Margin % distribution charts can be found below:
* The bar in red indicates where AngioDynamics's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AngioDynamics (STU:UG2) has a OCF Margin % of 20.15% as of May. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AngioDynamics and its competitors. This is 4012% above median its historical median of 0.49. According to the industry distribution chart, AngioDynamics ranks #482 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 59%.
Is AngioDynamics' OCF Margin % too high?
AngioDynamics' current OCF Margin % of 20.15% is 4012% above median its 10-year median of 0.49. The Medical Devices & Instruments industry median OCF Margin % is 5.82. AngioDynamics' value of 20.15% is 246.2% above this industry median. Based on the distribution chart, AngioDynamics ranks #482 out of 817 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, AngioDynamics has a GF Score™ of 64/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AngioDynamics' OCF Margin % compare to NNNN and OSUR?
According to the Medical Devices & Instruments industry distribution chart, AngioDynamics ranks #482 out of 817 companies for OCF Margin %. This places AngioDynamics in the lower half of its industry. The industry median OCF Margin % is 5.82. AngioDynamics' value of 20.15% is 246.2% above this benchmark. While the company's 10-year median is 0.49 vs. the industry median of 5.82, AngioDynamics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.82, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AngioDynamics's current OCF Margin % of 20.15% is 246.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on AngioDynamics and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.82 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AngioDynamics's current OCF Margin % is 20.15%, which is 4012% above median its own 10-year median of 0.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AngioDynamics stock overvalued right now?
Based on GuruFocus' analysis, AngioDynamics (STU:UG2) is currently considered Significantly Overvalued. The stock's GF Value™ is €8.32, compared to a current price of €11.80 — trading 41.8% above its estimated fair value. The current OCF Margin % is 20.15%, which is 4012% above median its 10-year median of 0.49 and 246.2% above the Medical Devices & Instruments industry median of 5.82. AngioDynamics' overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For AngioDynamics (STU:UG2), the current OCF Margin % is 20.15% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AngioDynamics (STU:UG2) Overvalued in 2026?
Based on GuruFocus' analysis, AngioDynamics stock appears to be overvalued.
The current stock price of €11.80 is trading 41.8% above its estimated GF Value™ of €8.32.
GuruFocus considers AngioDynamics to be Significantly Overvalued.
Key valuation signals for STU:UG2:
OCF Margin %: 20.15% (4012% above median its 10-year median of 0.49)
GF Value™: €8.32 vs. price of €11.80 (41.8% above fair value)
Industry Position: 246.2% above the Medical Devices & Instruments median (#482 of 817)
No single metric tells the full story. See the STU:UG2 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
64GF Score
Get the complete analysis for STU:UG2
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:UG2 has been successfully added to your 
